Major Depressive Disorder
Showing NaN - NaN of 50
MDD Trial in United States (OPC-34712, Placebo, ADT)
MDD Trial in Worldwide (Placebo, Vilazodone)
Completed
- Major Depressive Disorder
- Placebo
- Vilazodone
-
Beverly Hills, California
- +74 more
May 15, 2015
MDD Trial in Worldwide (Desvenlafaxine succinate sustained release 50 mg, Desvenlafaxine succinate sustained release 25 mg,
Completed
- Major Depressive Disorder
- Desvenlafaxine succinate sustained release 50 mg
- +2 more
-
Beverly Hills, California
- +88 more
Nov 6, 2014
MDD, MDD, Depression Trial in Puerto Rico, United States (TC-5214, Placebo)
Completed
- Major Depressive Disorder
- +2 more
- TC-5214
- Placebo
-
Birmingham, Alabama
- +93 more
Mar 14, 2014
MDD, Depression Trial in India, Puerto Rico, United States (TC-5214, Placebo)
Completed
- Major Depressive Disorder
- Depression
- TC-5214
- Placebo
-
Birmingham, Alabama
- +98 more
Mar 14, 2014
MDD Trial in United States (Dose-matched , Vilazodone)
Completed
- Major Depressive Disorder
- Dose-matched placebo
- Vilazodone
-
Beverly Hills, California
- +13 more
Feb 21, 2014
MDD Trial in United States (Vortioxetine, Duloxetine, Placebo)
Completed
- Major Depressive Disorder
- Vortioxetine
- +2 more
-
Beverly Hills, California
- +37 more
Oct 25, 2013
MDD Trial in Worldwide (Vortioxetine)
Completed
- Major Depressive Disorder
-
Beverly Hills, California
- +91 more
Oct 24, 2013
MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)
Completed
- Major Depressive Disorder
- Levomilnacipran ER
- Placebo
-
Birmingham, Alabama
- +50 more
Aug 22, 2013
MDD Trial in United States (Levomilnacipran ER, Placebo)
Completed
- Major Depressive Disorder
- Levomilnacipran ER
- Placebo
-
Phoenix, Arizona
- +37 more
Aug 22, 2013
MDD Trial in United States (Levomilnacipran ER, Placebo)
Completed
- Major Depressive Disorder
- Levomilnacipran ER
- Placebo
-
Dothan, Alabama
- +22 more
Aug 22, 2013
MDD Trial in United States (Lurasidone 20 mg, Lurasidone 60 mg, Placebo)
Withdrawn
- Major Depressive Disorder
- Lurasidone 20 mg
- +2 more
-
Birmingham, Alabama
- +26 more
Dec 11, 2012
MDD Trial in United States (F2695 SR)
Completed
- Major Depressive Disorder
- F2695 SR
-
Dothan, Alabama
- +67 more
Aug 15, 2012
MDD Trial in Canada, United States (Trazodone Hydrochloride (HCl) Extended-Release Tablets, Placebo)
Completed
- Major Depressive Disorder
- Trazodone Hydrochloride (HCl) Extended-Release Tablets
- Placebo
-
Birmingham, Alabama
- +36 more
Apr 24, 2012
MDD Trial in United States (desvenlafaxine succinate sustained-release, )
Completed
- Major Depressive Disorder
- desvenlafaxine succinate sustained-release
- placebo
-
Birmingham, Alabama
- +43 more
Mar 30, 2012
MDD Trial in Japan, United States (Desvenlafaxine Succinate Sustained-Release (DVS SR), )
Completed
- Major Depressive Disorder
- Desvenlafaxine Succinate Sustained-Release (DVS SR)
- placebo
-
Arcadia, California
- +77 more
Jun 8, 2011
MDD Trial in United States (Escitalopram, Placebo)
MDD Trial in United States (Quetiapine fumarate)
Completed
- Major Depressive Disorder
- Quetiapine fumarate
-
Phoenix, Arizona
- +55 more
Mar 24, 2009
MDD Trial in United States (Quetiapine fumarate)
Completed
- Major Depressive Disorder
- Quetiapine fumarate
-
Little Rock, Arkansas
- +36 more
Mar 24, 2009